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Abstract
Background: Cancer screening awareness and participation may be lower in low- and middle-income countries
that lack established national screening programmes compared with those that do. We evaluated potential
determinants of awareness about and participation in breast and cervical cancer screening, and breast self-
examination (BSE) in women using survey data from Indonesia.
Methods: From the fifth Indonesian Family Life Survey (2014–2015), a total of 5397 women aged 40 and older
without any history of cancer who responded to questionnaires concerning Pap smears, mammography, and BSE
were included. Multilevel modelling was used to assess potential determinants in relation to awareness about Pap
smears and mammography, and participation in Pap smears and BSE practice. Multivariable analyses were
performed to identify independent predictors of cancer screening.
Results: Of the 5397 respondents, 1058 (20%) women were aware of Pap smears, of which 297 had never had the
procedure. Only 251 (5%) participants were aware of mammography. A total of 605 (12%) of women reported they
performed BSE. Higher education and household expenditure were consistently associated with higher odds of
awareness about Pap smears and mammography (e.g. odds ratio [OR] of being aware of Pap smear and
mammography: 7.82 (95% CI: 6.30–9.70) and 7.70 (6.19–9.58), respectively, for high school graduates compared to
women with less educational attainment in the multivariable models), and participation in Pap smears and BSE. We
also identified enabling factors linked with greater cancer screening awareness and participation, including health
insurance, shorter distance to health services, and social participation.
Conclusion: There are socioeconomic disparities in cancer screening awareness and participation among
Indonesian women. Our findings may help inform targeted health promotion and screening for cancer in the
presence of limited resources.
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Background
The overall burden of cancer has been increasing in de-
veloping countries [1]. The World Health Organization
(WHO) International Agency for Research on Cancer
(IARC) estimated that there will be up to 21.7 million
new cancer cases and 13 million cancer-related deaths in
2030, with 70% of those cases in low- to middle-income
countries (LMICs) [2–4]. Although cancer mortality
rates have declined in high-income countries, LMICs
have seen elevated cancer-related mortality rates [5],
owing to a lack of cancer prevention and screening pro-
grammes and limited resources to treat cancer [4, 6].
In LMICs such as Indonesia, cancers are mostly diag-
nosed at an advanced stage, in which curative treatment
is often no longer possible [7]. For female cancers, breast
and cervical cancers remain the leading causes of cancer
mortality in Indonesia (21% and 10%, respectively) [5].
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Yet, affordable cervical cancer screening is only available
in eight of 34 provinces in Indonesia, [5, 8] with low
awareness and uptake of breast and cervical cancer
screening [5, 8, 9]. The low uptake may be attributable
to a range of barriers including a lack of knowledge
about cancer prevention as well as widespread miscon-
ceptions and fears about cancer and its treatment [9, 10]
also further contribute to the late presentation of disease
[11]. In addition, there are often inequalities in the dis-
tribution of healthcare workers throughout the country,
resulting in inequalities in healthcare access especially
between urban and rural areas [12]. Nonetheless, the ex-
tent of inequalities in cancer screening awareness and
participation in LMICs, such as Indonesia, is often un-
clear. Additionally, breast self-examination (BSE) as a
tool to screen for breast cancer is common in these
countries, although there is evidence to suggest that this
technique lacks effectiveness [13].
We performed a cross-sectional study of 5397 cancer-
free Indonesian women aged 40 and older, the target
group for breast and cervical cancer screening based on
American Cancer Society Guidelines [14]. We used
multilevel regression analyses to identify potential deter-
minants of cervical and breast cancer screening aware-
ness and participation to gain further insight into
predisposing, enabling, and need factors which could po-
tentially inform targeted prevention programmes in low-
resource settings.
Methods
Study population
The Indonesian Family Life Survey (IFLS) is a longitu-
dinal household survey in Indonesia containing informa-
tion from questionnaires, as well as physical and
laboratory examinations. Data were collected at individ-
ual, household, and community levels. The first IFLS
(IFLS1) used a stratified sampling scheme based on
provinces and urban/rural location. For cost-
effectiveness, 14 of the 27 provinces that existed at the
time IFLS1 was conducted were excluded [15]. The
resulting sample included 13 of Indonesia’s 27 provinces,
containing 83% of the population: four provinces on
Sumatra (North Sumatra, West Sumatra, South Sumatra,
and Lampung), all five of the Javanese provinces (DKI
Jakarta, West Java, Central Java, DI Yogyakarta, and East
Java), and four provinces covering the remaining major
island groups (Bali, West Nusa Tenggara, South
Kalimantan, and South Sulawesi). Within each province,
enumeration areas (EAs) were randomly chosen from a
nationally representative sample frame used in a socio-
economic survey of about 60,000 households in 1993
[15]. Within a selected EA, households were randomly
selected. Interviews were carried out with the household
head and the spouse, and up to 4 randomly selected
other household members as interviewing all members
of the household would have been too costly. All mem-
bers of the original household were followed up through
four subsequent IFLS waves. The present study was
based on the fifth wave of IFLS (IFLS5), conducted in
2014–2015. Both original and split-off households were
tracked in the IFLS5, resulting in a 76% re-contact rate
(including death) for the original IFLS1 household mem-
bers, and 82% for IFLS1 main respondents. From the
IFLS5, we included a total of 5397 women aged 40 and
older without a self-reported history of cancer who
responded to the questions on Pap smears, mammog-
raphy, and BSE (Additional file 1: Fig. S1).
Cancer screening participation and behaviour
The outcomes of the present study measured awareness
of Pap smears and mammography, and participation in
Pap smears and BSE practice. All responses were self-
reported and dichotomous (yes, no). First, during the
interview, respondents were asked if they had ever heard
of a Pap smear. Those who responded positively to this
question were further asked whether they had ever re-
ceived a Pap smear in their life, and, if so, when. Partici-
pants were also asked whether they had ever heard
about mammography, and those who responded posi-
tively were asked whether they had ever received a
mammography in the past year. All study participants
were asked how many times they had performed BSE in
the past year, and we further dichotomised them into
those who had performed BSE and who had not.
Potential determinants of screening
The Anderson model of healthcare-use behaviour [16]
was used to identify potential determinants of cancer
screening awareness and participation. This model in-
cludes three domains: predisposing, enabling, and need
factors, which interact in determining one’s health-
related behaviour. From IFLS5 (Fig. 1), predisposing
sociodemographic and lifestyle characteristics of the pa-
tients were collected including age, ethnicity, urban or
rural residence, marital status, education, monthly
household expenditure, smoking status, physical activity
and personality traits. Ethnicity was categorised into
Javanese, which comprises the majority of Indonesians,
and non-Javanese. Education was categorised based on
the highest level (less than high school, high school,
higher education). Household expenditure was calcu-
lated based on the total of food, non-food, and education
expenditure [17]. Smoking history was used to classify
individuals into current, former, and never smokers. Par-
ticipants were defined as vigorously active if they re-
ported participating in more than two vigorous physical
activities in the past week for at least 10 min each, [18]
moderately active if they participated more than 4 times
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in the past week in moderate to vigorous physical activ-
ities of which no more than two could be considered
vigorous. Lightly active was defined as participating in
any activities or walking at least 30 min each time, for
more than 2 times in the past week but did not meet the
description of vigorously or moderately active. Those
who reported no moderate or vigorous physical activity
and walked fewer than 3 times a week were categorised
as sedentary. Personality traits were assessed with a
short (15-item) Big Five Inventory (BFI-15) question-
naire [19], with scores ranging from 1 to 5 for openness,
conscientiousness, extroversion, agreeableness, and
neuroticism.
Enabling factors identified in the population included
health insurance ownership and travel distance in mi-
nutes to the nearest healthcare centre, and participation
in any social activities within the past year. On 1 January
2014, the Indonesian government launched a compul-
sory national health insurance,which covers Pap smears
[20], although this scheme has yet to cover mammog-
raphy. However, unequal healthcare access issues were
reported within the first year of the scheme being imple-
mented (2014–2015) [21], which is the period in which
the present study took place. Therefore, we took into ac-
count self-reported insurance coverage in our analysis.
Factors representing needs for cancer screening included
information on reproductive factors: menopausal status,
age at menarche, co-morbidities, parental history of can-
cer death, and body mass index (BMI) calculated from
measured weight and height during physical examin-
ation. Co-morbidities were assessed as a comorbidity
score similar to the Charlson co-morbidity index, where
each co-morbid condition available (hypertension, dia-
betes, asthma, heart disease, liver disease, stroke, cancer,
arthritis, kidney disease, stomach or digestive disease,
and memory-related disease) contributed one point to
the composite index with additional points given for
older age. Finally, to assess the role of mental health, de-
pression was measured with a short version (10-item) of
the Center for Epidemiologic Studies Depression Scale
(CES-D), [15] and a cut-off of 8 was used for a screening
of depressive symptoms [19].
Statistical analysis
We analysed the association between each determinant
with awareness of Pap smears, awareness of mammog-
raphy, ever-Pap smear, and performed BSE. We did not
assess use of mammography as an outcome given the
small number of participants with a positive response.
To take into account the IFLS sampling design, we per-
formed multilevel logistic regression analyses to obtain
odds ratios (ORs) and their 95% CI for associations be-
tween each determinant and outcome. Community clus-
tering was used as a random effect in a two-level
multivariable model. Household clustering was not used
in the multilevel model due to there being an inadequate
number of participants for generating meaningful statis-
tical results for a number of factors. However, where
possible, we compared models using both community
and household clustering with models using only com-
munity clustering with analysis of co-variance, and no
difference was observed between these models (P > 0.05).
Univariable analyses were conducted for all potential de-
terminants of cancer screening awareness and practice.
These factors comprised different components of the
Anderson model [16], ranging from predisposing factors
such as sociodemographic characteristics (e.g. marital
status, education, income), enabling factors, which in-
cluded healthcare access. We additionally included co-
morbid conditions (e.g. diabetes, obesity as measured by
BMI) given the evidence linking comorbidity to cervical
and breast cancer screening participation in Western
Fig. 1 Potential determinants of cancer screening awareness and participation in IFLS5 based on the Anderson model of health behaviour
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populations [22]. Multivariable analyses were further car-
ried out and included factors which showed significant as-
sociations with cancer awareness or participation in the
univariable models. We performed a sensitivity analysis by
grouping participants into those who had performed BSE
more than once and those who had. The dataset was pre-
pared with SAS release 9.3 (SAS Institute, Cary, NC).
Logistic regression with multilevel modelling was per-
formed with the lme4 package in R version 3.3.2 (R
Foundation for Statistical Computing, Vienna, Austria).
Results
Characteristics of the study participants (N = 5397) are
presented in Table 1. The mean age of participants was
52.9 years. The majority of women were of Javanese eth-
nicity, married, lived in urban areas, and had not com-
pleted high school. Nearly a quarter (23%) of women
had three or more co-morbidities, and a similar propor-
tion were overweight (BMI ≥ 25 kg/m2). Only 1058
(20%) women were aware of Pap smears and 297 among
them had undergone at least one Pap smear in their life-
time. A total of 251 (5%) participants were aware of
mammography, among which five had had a mammo-
gram in the previous year. Twelve percent of women re-
ported they had performed BSE in the past year. We
additionally present the demographic characteristics of
women who did not respond to questions on cancer
screening (Additional file 1: Table S1), which comprised
9.6% of women aged 40 and older. Compared to women
who provided a response to cancer screening, non-
responders were in average older, less educated, had
lower household expenditure, and more likely to be
non-Javanese or unmarried.
Determinants of awareness of pap smears
Table 2 shows potential determinants of awareness of
Pap smears identified through univariable regressions
and grouped according to the Anderson model. Some
categories, for instance education levels, were merged in
the analysis due to the limited numbers of participants.
In the analysis, age, ethnicity, urban residence, marital
status, education level, household expenditure, physical
activity, openness, extroversion, agreeableness, neuroti-
cism, insurance, distance to healthcare providers, meno-
pausal status, age at menarche, comorbidity score,
parental deaths of cancer, overweight, and CESD were
associated with awareness of Pap smears. In the multi-
variable analysis (Table 4), being Javanese (OR: 1.91, 95%
CI: 1.52–2.40), living in urban area (OR: 4.28, 3.22–
5.67), graduating high school (OR: 7.82, 6.30–9.70),
greater household expenditure (OR: 2.31, 1.91–2.80),
physical activity (OR: 1.54, 1.25–1.91), agreeable (1.63,
1.30–2.03) and neuroticism traits (OR: 1.23, 1.02–1.49),
having insurance (OR: 2.05, 1.69–2.49), and participating
Table 1 Characteristics of study participants (N = 5397)
Potential determinants N (%)
Predisposing
Age 40–60 4098 (75.93)
≥60 1299 (24.07)
Ethnicity Not Javanese 2900 (43.73)
Javanese 2497 (46.27)
Residence Rural 2339 (43.34)
Urban 3058 (56.66)
Marital status Not married 1423 (26.37)
Married 3974 (73.63)
Education Less than high school 3534 (65.48)
High school 1529 (28.33)
Higher education 334 (6.19)
Monthly household expenditure Tertile 1–2 3561 (65.98)
Tertile 3 1836 (34.02)
Tobacco smoking Never 5157 (95.55)
Former 63 (1.17)
Ever 177 (3.28)
Physical activity Sedentary 1627 (30.15)
Lightly active 1793 (33.22)
Moderately active 1460 (27.05)
Vigorously active 517 (9.58)
Openness < 4 4715 (87.36)
≥4 682 (12.64)
Conscientiousness < 4 4690 (86.90)
≥4 707 (13.10)
Extroversion < 4 3203 (59.35)
≥4 2194 (40.65)
Agreeableness < 4 1771 (32.81)
≥4 3626 (67.19)
Neuroticism < 4 3191 (59.13)
≥4 2206 (40.87)
Enabling
Insured No 2754 (51.03)
Yes 2643 (48.97)
Travel time < 10 min 4503 (83.44)
≥10 min 894 (16.56)
Participating in social activities No 806 (14.93)
Yes 4591 (85.07)
Need
Menopausal status Premenopausal 2300 (42.61)
Postmenopausal 3097 (57.38)
Age at menarche < 14 2133 (39.52)
≥ 14 3264 (60.48)
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in social activities (OR: 2.12, 1.50–2.98) corresponded to
higher likelihood of being aware of Pap smears. As
shown in Table 4, a decrease in the odds of Pap smear
awareness was shown as the distance to a healthcare
provider increased (OR: 0.73, 0.55–0.98) and CESD
score (OR: 0.68, 0.55–0.85) in the multivariable model.
Determinants of awareness of mammography
Similar patterns of associations between potential pre-
dictors and awareness of Pap smears were observed for
awareness of mammography in the univariable analysis
(Table 2). In the multivariable model, we found higher
odds of being aware of mammography in women living
in urban areas (OR: 4.51, 95% CI: 3.36–6.06), women
who had graduated high school (OR: 7.70, 6.19–9.58),
women with higher household expenditure (OR: 2.28,
1.88–2.76), women that do physical activity (OR: 1.54,
1.24–1.90), women who have greater agreeableness (OR:
1.67, 1.33–2.09), women with neuroticism traits (OR:
1.24, 1.03–2.09), women who have insurance (OR: 2.01,
1.65–2.44), and women who participate in social activ-
ities (OR: 2.29, 1.62–3.23) (Table 4). Living further from
health services (OR: 0.70, 0.52–0.94) and being postmen-
opausal (OR: 0.79, 0.63–0.99) were inversely associated
with being aware of mammography in the multivariable
model.
Determinants of pap smear participation
We assessed factors associated with participation in
Pap smears (Table 3), and only found education level,
household expenditure, insurance, menopausal status
and comorbidity score to be associated with participa-
tion in Pap smears in the univariable analysis. In the
multivariable models, women were more likely to
have had a Pap smear if they had graduated high
school (OR: 1.58, 95% CI: 1.04–2.41), had higher
household expenditure (OR: 1.94, 1.40–2.69), had
insurance (1.57 (1.12–2.22), and had two or more co-
morbidities (1.45, 1.01–2.08) (Table 4).
Determinants of BSE practice
A number of factors were associated with having performed
BSE in the past year in univariable analyses (Table 3). In the
multivariable analysis, those associated with higher odds of
practicing BSE were living in urban areas (OR: 1.97, 95%
CI: 1.54–2.51), had higher education (OR: 4.26, 3.39–5.36),
had higher household expenditure (OR: 1.68, 1.38–2.05),
had higher agreeable traits (OR: 1.61, 1.26–2.05), had insur-
ance (OR: 1.44, 1.18–1.76), and engaged in social activities
(OR: 2.00, 1.38–2.88) (Table 4). A borderline association
was shown for physical activity (OR: 1.24, 95% CI: 1.00–
1.54) and having menarche at age 14 or older (OR: 0.95,
0.90–1.00 compared to at younger ages) in the multivari-
able model.
Sensitivity analyses
Results were also similar when we used BSE at least twice
(N = 723) instead of once in the past year (N = 796) to de-
fine women who practiced BSE as the outcome, but this
did not alter our findings (data not shown).
Discussion
Our study identified predisposing, enabling, and need fac-
tors associated with awareness of cancer screening and
participation in Indonesian women. Most persistent asso-
ciations were observed for socio-economic determinants,
particularly higher education, household expenditure, and
ownership of health insurance, which were associated with
higher awareness of Pap smears and mammography, and
higher odds of participating in Pap smears and BSE. A
similar positive association was observed for social activity
participation with awareness of Pap smears and BSE prac-
tice, whereas distance to nearest health centres was in-
versely associated with awareness of Pap smears and
mammography. Our findings also uncovered associations
between personality traits, and Pap-smear awareness and
participation and BSE practice which remained when tak-
ing into account other determinants.
Despite the increasing cancer burden, most LMICs are
yet to publish national guidelines for screening and early
detection of breast and cervical cancers [5, 23]. In other
LMICs in which national cancer screening programmes
have been introduced, such as those in the Middle East
and North Africa where screening ranges from 2% to
70% of the at-risk population, improving participation
rates remains a challenge [24]. In Sub-Saharan Africa,
fewer than 5% of women at risk are estimated to have
been screened for cervical cancer [25, 26]. Population-
based cervical cancer screening programmes have been
in place for more than 10 years in India, however, par-
ticipation rates are also relatively low [27, 28]. The
Table 1 Characteristics of study participants (N = 5397)
(Continued)
Potential determinants N (%)
Co-morbidity score 0 1476 (27.35)
1 1506 (27.90)
2 1162 (21.53)
3 and more 1253 (23.22)
Parent died from cancer No 5264 (97.54)
Yes 133 (2.46)
BMI < 25 kg/m2 2879 (53.34)
≥ 25 kg/m2 2518 (46.66)
CES-D < 8 5097 (94.44)
≥ 8 300 (5.66)
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Table 2 Univariable associations of potential determinants with cancer screening awareness among women 40 years and older
without known history of any cancer
Potential determinants Aware of Pap smear (N = 5397) Aware of mammography (N = 5397)
N (%) OR (95% CI) N (%) OR (95% CI)
Predisposing
Age 40–60 919 (22.42) Ref 220 (5.37) Ref
≥60 139 (10.70) 0.32 (0.25–0.40) 31 (2.39) 0.44 (0.43–0.45)
Ethnicity Not Javanese 478 (16.48) Ref 146 (5.03) Ref
Javanese 580 (23.23) 1.49 (1.18–1.88) 105 (4.21) 0.85 (0.59–1.22)
Residence Rural 166 (7.09) Ref 54 (2.31) Ref
Urban 892 (29.16) 7.74 (5.77–10.37) 197 (6.44) 3.57 (2.34–5.44)
Marital status Not married 193 (13.56) Ref 43 (3.02) Ref
Married 865 (21.77) 2.14 (1.74–2.62) 208 (5.23) 1.93 (1.34–2.75)
Education Less than high school 223 (5.31) Ref 70 (1.98) Ref
High school or higher education 835 (44.82) 14.01 (11.44–17.16) 181 (9.72) 5.08 (3.75–6.90)
Monthly household expenditure Tertile 1–2 446 (12.52) Ref 95 (2.67) Ref
Tertile 3 612 (33.33) 3.66 (3.08–4.35) 156 (8.50) 3.29 (2.49–4.33)
Tobacco smoking Never 1019 (19.76) Ref 241 (4.67) Ref
Ever 39 (16.25) 0.78 (0.50–1.21) 10 (4.17) 0.87 (0.43–1.76)
Physical activity Active 268 (16.47) Ref 51 (3.13) Ref
Sedentary 790 (20.95) 1.49 (1.23–1.80) 200 (5.31) 1.85 (1.32–2.60)
Openness < 4 957 (20.30) Ref 226 (4.79) Ref
≥4 101 (14.81) 0.77 (0.59–1.00) 25 (3.67) 0.94 (0.62–1.44)
Conscientiousness < 4 929 (19.81) Ref 218 (4.64) Ref
≥4 129 (18.25) 1.00 (0.78–1.28) 33 (4.67) 1.02 (0.69–1.53)
Extroversion < 4 688 (21.48) Ref 167 (5.21) Ref
≥4 370 (16.86) 0.75 (0.63–0.88) 84 (3.83) 0.76 (0.57–1.00)
Agreeableness < 4 199 (11.24) Ref 50 (2.82) Ref
≥4 859 (23.69) 2.53 (2.08–3.08) 201 (5.54) 1.91 (1.37–2.64)
Neuroticism < 4 528 (16.55) Ref 111 (3.48) Ref
≥4 530 (24.03) 1.65 (1.40–1.95) 140 (6.35) 1.88 (1.87–1.89)
Enabling
Insured No 340 (12.35) Ref 82 (2.98) Ref
Yes 718 (27.17) 2.52 (2.11–3.01) 169 (6.39) 2.10 (1.57–2.82)
Travel time < 10 min 952 (21.14) Ref 232 (5.15) Ref
≥10 min 106 (11.86) 0.48 (0.37–0.62) 19 (2.12) 0.42 (0.26–0.70)
Participating in social activities No 65 (8.06) Ref 20 (2.48) Ref
Yes 993 (21.63) 3.27 (2.39–4.47) 231 (5.03) 2.25 (1.35–3.75)
Need
Menopausal status Premenopausal 641 (27.87) Ref 160 (6.96) Ref
Postmenopausal 417 (13.46) 0.36 (0.30–0.42) 91 (2.94) 0.41 (0.31–0.54)
Age at menarche < 14 472 (22.13) Ref 115 (5.39) Ref
≥ 14 586 (17.95) 0.77 (0.65–0.91) 136 (4.17) 0.73 (0.56–0.95)
Co-morbidity score 0–1 692 (23.21) Ref 179 (6.00) Ref
≥ 2 366 (15.15) 0.53 (0.45–0.63) 72 (2.98) 0.54 (0.40–0.72)
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Indonesian Ministry of Health has recently released new
recommendations for preventive measures against cer-
vical and breast cancer (PERMENKES RI No.34/2015)
[29]. Approximately 34.5 million Indonesian women are
expected to participate in this breast and cervical cancer
screening program [29]. According to government rec-
ommendations, health promotion should be conducted
through public events, media, religious communities,
and other civic society channels. Preventive measures in-
clude mass screening, mainly for cervical cancer using
visual inspection with acetic acid, should be organised as
public events. Women in the target age groups may also
request examinations for early detection at healthcare fa-
cilities. However, no formal invitation for screening is
sent to individuals, and there is a lack of clear guidelines
regarding the use of mammography. In 2015, only
904,099 (4.94%) women had completed screening and
early detection examination for breast and cervical can-
cer, a similar figure to that observed in this study. The
target coverage, however, is 50% by 2019 [29].
Most women in developing countries seek medical
care after they develop symptoms. For instance, more
than 70% of cervical cancer patients in developing coun-
tries visited a hospital once their cancer had already
infiltrated the parametrium [30, 31]. A population
based-study conducted in Indonesia demonstrated that
implementation of small-scale cervical cancer screening
project reached only 24% of females in the target group
despite the implementation of a mobile screening service
to reach more inaccessible areas [32]. We did not find
any report evaluating existing programmes or interven-
tion approaches for breast cancer screening. However, it
is worth noting that mammography and breast ultrason-
ography are currently only covered by the national uni-
versal health insurance in particular health facilities,
which may explain the low cancer screening awareness
and participation more generally.
Only a few studies have addressed the role of mental
health and personality traits in cancer screening aware-
ness and participation in LMICs [33, 34]. In our study, a
higher CES-D score, which is linked to symptoms of
depression, was associated with low awareness of Pap
smears, but higher odds of BSE practice. This corroborates
previous findings linking stress and depression, which are
generally more common in individuals of low SES [35],
with health-related behaviours [34]. Community support
might be required to achieve the desirable level of aware-
ness and participation in cancer screening, especially in
women with psychiatric comorbidities. We found associa-
tions between higher agreeableness and higher awareness
of Pap smears and BSE practice, whereas higher neuroti-
cism was linked with higher awareness of cancer screen-
ing. Using a similar approach, two studies also reported
associations between personality traits and cancer-related
health behaviours, with higher conscientiousness associ-
ated with higher participation in bowel and prostate can-
cer screenings [36, 37]. The positive correlation between
conscientiousness and cancer screening awareness did not
reach statistical significance in our study. However, our
findings support the use of personality-tailored ap-
proaches to raise awareness of and participation in cancer
screening among women.
As shown in our study and previous ones, sociodemo-
graphic determinants including household socio-
economic status, ethnicity [38], rural residence, health ex-
penditure, and healthcare access [38] are associated with
participation in breast and cervical cancer screening [39].
In addition to these factors, we demonstrated that existing
comorbidities were associated with awareness of and par-
ticipation in screening of breast and cervical cancers.
These findings may indicate a complex relationship be-
tween health and sociodemographic factors in determin-
ing population awareness of, and participation in cancer
screening. Therefore, multiple health policies are required
to improve the public’s awareness of screening and other
initatives as well as the healthcare system’s ability to de-
liver these initiatives. Interventions may also be needed to
advance the skills of primary caregivers for detecting
breast and cervical cancer, to promote prompt referrals, to
strengthen the system’s capacity for diagnostic imaging,
cytology, and histopathology, and to deliver multimodal
breast and cervical cancer treatment. Moreover, an
Table 2 Univariable associations of potential determinants with cancer screening awareness among women 40 years and older
without known history of any cancer (Continued)
Potential determinants Aware of Pap smear (N = 5397) Aware of mammography (N = 5397)
N (%) OR (95% CI) N (%) OR (95% CI)
Parent died from cancer No 1009 (19.17) Ref 238 (4.52) Ref
Yes 49 (36.84) 2.58 (1.62–4.11) 13 (9.77) 2.25 (1.15–4.41)
BMI < 25 kg/m2 457 (15.87) Ref 121 (4.20) Ref
≥ 25 kg/m2 601 (23.87) 1.49 (1.26–1.76) 130 (5.12) 1.12 (0.85–1.48)
CES-D < 8 820 (21.42) Ref 190 (4.96) Ref
≥ 8 238 (15.18) 0.73 (0.60–0.88) 61 (3.89) 0.86 (0.63–1.17)
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Table 3 Univariable associations of potential determinants with cancer screening practice among women 40 years and older
without known history of any cancer
Potential determinants Ever Pap smear (N = 1058) Performed BSE (N = 5397)
N (%) OR (95 CI) N (%) OR (95 CI)
Predisposing
Age 40–60 254 (27.64) Ref 538 (13.13) Ref
≥60 43 (30.94) 1.06 (0.55–2.03) 67 (5.16) 0.33 (0.25–0.43)
Ethnicity Not Javanese 133 (27.82) Ref 302 (10.41) Ref
Javanese 164 (28.28) 0.58 (0.72–1.33) 303 (12.13) 1.20 (0.96–1.51)
Residence Rural 50 (30.12) Ref 129 (5.52) Ref
Urban 247 (27.69) 0.85 (0.56–1.28) 476 (15.56) 3.54 (2.74–4.58)
Marital status Not married 52 (26.94) Ref 99 (6.96) Ref
Married 245 (28.32) 1.10 (0.76–1.60) 506 (12.73) 2.06 (1.62–2.61)
Education Less than high school 48 (21.52) Ref 141 (3.99) Ref
High school or higher education 249 (29.82) 1.70 (1.16–2.50) 464 (24.91) 8.24 (6.67–10.18)
Monthly household expenditure Tertile 1–2 92 (20.63) Ref 265 (7.44) 1.70 (1.54–1.88)
Tertile 3 205 (33.50) 2.08 (2.07–2.09) 340 (18.52)
Tobacco smoking Never 286 (28.07) Ref 580 (11.25) Ref
Ever 11 (28.21) 1.06 (0.50–2.26) 25 (10.42) 0.95 (0.60–1.51)
Physical activity Active 72 (26.87) Ref 157 (9.64) Ref
Sedentary 225 (28.48) 1.12 (0.80–1.56) 448 (11.88) 1.30 (1.06–1.60)
Openness < 4 272 (28.42) Ref 544 (11.54) Ref
≥4 25 (24.75) 0.89 (0.55–1.45) 61 (8.94) 0.79 (0.59–1.07)
Conscientiousness < 4 264 (28.42) Ref 531 (11.32) Ref
≥4 33 (25.58) 0.83 (0.53–1.29) 74 (10.47) 0.95 (0.72–1.25)
Extroversion < 4 199 (28.92) Ref 400 (12.49) Ref
≥4 98 (26.49) 0.96 (0.72–1.30) 205 (9.34) 0.74 (0.61–0.90)
Agreeableness < 4 59 (29.65) Ref 107 (6.04) Ref
≥4 238 (27.71) 0.97 (0.69–1.39) 498 (13.73) 2.48 (1.98–3.11)
Neuroticism < 4 135 (25.57) Ref 294 (9.21) Ref
≥4 162 (20.57) 1.31 (0.99–1.74) 311 (14.09 1.61 (1.34–1.93)
Enabling
Insured No 76 (22.35) Ref 217 (7.87) Ref
Yes 221 (30.78) 1.70 (1.23–2.37) 388 (14.68) 1.97 (1.63–2.39)
Travel time < 10 min 275 (28.87) Ref 545 (12.10) Ref
≥10 min 22 (20.75) 0.61 (0.36–1.02) 60 (6.71) 0.52 (0.39–0.70)
Participating in social activities No 13 (20.00) Ref 38 (4.71) Ref
Yes 284 (28.60) 1.56 (0.81–3.00) 567 (12.35) 2.85 (1.99–4.08)
Need
Menopausal status Premenopausal 163 (25.42) Ref 403 (17.52) Ref
Postmenopausal 134 (32.13) 1.38 (1.04–1.85) 202 (6.52) 0.32 (0.26–0.38)
Age at menarche < 14 138 (29.24) Ref 274 (12.85) Ref
≥ 14 159 (27.13) 0.87 (0.65–1.15) 331 (10.14) 0.80 (0.66–0.96)
Co-morbidity score 0–1 73 (25.29) Ref 412 (13.82) Ref
≥ 2 58 (33.33) 1.58 (1.18–2.12) 193 (7.99) 0.52 (0.43–0.63)
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effective nationwide cancer registry needs to be estab-
lished to map cancer incidence and to coordinate screen-
ing and evaluation efforts.
The main strength of this study lies in the large number
of participants, who live in areas covering 83% of the popu-
lation in Indonesia in 1993. We were able to account for
community clustering and various potential determinants
of cancer screening awareness and participation in women.
A limitation of this study was that cancer screening
awareness only relied on dichotomous responses of ques-
tionnaires, without any additional responses allowing for
cross-validation and potentially more qualitative work.
Additionally, most information was self-reported. However,
any misclassification is likely to have been non-differential.
Table 3 Univariable associations of potential determinants with cancer screening practice among women 40 years and older
without known history of any cancer (Continued)
Potential determinants Ever Pap smear (N = 1058) Performed BSE (N = 5397)
N (%) OR (95 CI) N (%) OR (95 CI)
Parent died from cancer No 281 (27.85) Ref 573 (10.89) Ref
Yes 16 (32.65) 1.30 (0.68–2.50) 32 (24.06) 2.42 (1.54–3.83)
BMI < 25 kg/m2 119 (26.04) Ref 264 (9.17) Ref
≥ 25 kg/m2 178 (29.62) 1.18 (0.89–1.58) 341 (13.54) 1.44 (1.20–1.74)
CES-D < 8 235 (28.66) Ref 439 (11.47) Ref
≥ 8 62 (26.05) 0.91 (0.65–1.28) 166 (10.59) 0.99 (0.81–1.22)
Table 4 Multivariable associations of potential determinants with cancer screening awareness among women 40 years and older
without known history of any cancer
Potential determinantsa OR (95% CI)
Aware of pap smear Aware of mammography Ever pap smear Performed BSE
Predisposing
Age 0.72 (0.52–0.99) 0.74 (0.53–1.01) 0.82 (0.58–1.18)
Javanese 1.91 (1.52–2.40)
Urban residence 4.28 (3.22–5.67) 4.51 (3.36–6.06) 1.97 (1.54–2.51)
Married 1.12 (0.88–1.43) 1.13 (0.88–1.44) 1.10 (0.85–1.44)
High school or higher education 7.82 (6.30–9.70) 7.70 (6.19–9.58) 1.58 (1.04–2.41) 4.26 (3.39–5.36)
Monthly household expenditure – higher tertile 2.31 (1.91–2.80) 2.28 (1.88–2.76) 1.94 (1.40–2.69) 1.68 (1.38–2.05)
Physically active 1.54 (1.25–1.91) 1.54 (1.24–1.90) 1.24 (1.00–1.54)
Openness ≥4 0.90 (0.67–1.22)
Extroversion ≥4 0.87 (0.71–1.05) 0.83 (0.69–1.01) 0.83 (0.68–1.02)
Agreeableness ≥4 1.63 (1.30–2.03) 1.67 (1.33–2.09) 1.61 (1.26–2.05)
Neuroticism ≥4 1.23 (1.02–1.49) 1.24 (1.03–2.09) 1.19 (0.98–1.44)
Enabling
Have insurance 2.05 (1.69–2.49) 2.01 (1.65–2.44) 1.57 (1.12–2.22) 1.44 (1.18–1.76)
Travel ≥10 min to health service 0.73 (0.55–0.98) 0.70 (0.52–0.94) 0.76 (0.56–1.03)
Participating in social activities 2.12 (1.50–2.98) 2.29 (1.62–3.23) 2.00 (1.38–2.88)
Need
Postmenopausal 0.76 (0.61–0.96) 0.79 (0.63–0.99) 1.29 (0.90–1.83) 0.58 (0.56–1.03)
Age at menarche ≥14 0.98 (0.93–1.02) 0.98 (0.93–1.03) 0.95 (0.90–1.00)
Co-morbidity score≥ 2 1.18 (0.92–1.50) 1.09 (0.86–1.40) 1.45 (1.01–2.08) 1.10 (0.85–1.41)
Parent died from cancer 1.50 (0.90–2.50) 1.50 (0.89–2.52) 1.59 (0.99–2.54)
BMI≥ 25 kg/m2 1.15 (0.95–1.39) 1.07 (0.89–1.30)
CES-D≥ 8 0.68 (0.55–0.85)
aFor categorical factors, odds ratios (ORs) were shown for categories displayed in the left-hand column in comparison with the remaining categories as the reference
(see Table 2-3)
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We did not use specific cancer questionnaires to measure
awareness such as the UK Cancer Awareness Measure [40],
since the survey was not originally designed for this par-
ticular purpose. Development and validation of a cancer
awareness measurement tool that is socioculturally relevant
to the Indonesian population is therefore necessary to re-
fine our understanding of the variability in awareness of
cancer screening in Indonesia. We were only able to cap-
ture mammography use in the past year due to data avail-
ability, and this may be a subject of further investigations. It
should also be noted that less educated women may have
been less familiar with certain medical terminology, al-
though in Indonesia, the terms ‘Pap smear’ and ‘mammog-
raphy’ are commonly used in the primary care settings [29].
However, we still observed associations between other fac-
tors and awareness to either Pap smears or mammography
when adjusting for educational levels. Spurious correlations
may be of concern when performing multiple comparisons
as shown in our study. However, we planned our analyses
based on a priori models and our results are explained by
potential socioeconomic and health-related mechanisms,
and are confirmed by findings from other studies. There-
fore, the observed association is unlikely to be spurious
[41], although a discrepancy with the strength of the true
association is possible due to the small number of partici-
pants. Women who responded to screening questionnaires
may have different characteristics compared to all women
aged 40 and older. Furthermore, although IFLS5 covered
most respondents from the original IFLS1 survey, there
have been rapid demographic changes in Indonesia [42].
These patterns may reduce the generalisability of our find-
ings. However, demographic transition is well-reflected in
the study population, such as the greater number of women
living in urban areas in IFLS5 as opposed to the majority
living in rural areas in 1993 [42]. Furthermore, this cohort
effect is unlikely to affect the internal validity of the results.
Finally, our analyses were cross-sectional and only imply
associations. Untangling causal associations is necessary to
identify key modifiable factors that improve or worsen
awareness of and participation in cancer screening.
Conclusion
We identified a number of factors associated with cervical
and breast cancer screening awareness and practice in
Indonesia. Improvement of enabling factors such as access
to healthcare and social participation may help enhance
cancer screening in low-resource settings, particularly
among subgroups of women who are socio-economically
susceptible to a low awareness of cancer screening. The dif-
ferent associations observed with different personality traits
support the potential benefit of employing a range of strat-
egies to promote cancer awareness and participation in
Indonesia and potentially other LMICs that lack long-
established cancer screening programmes.
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